Manager of Parkway Life REIT

Board Of Directors

The Board is entrusted with the responsibility for the overall management of the Manager. The Board of Parkway Trust Management Limited comprises:

  • MR. HO KIAN GUAN, Independent Director and Chairman of the Board of Directors and Member of the Audit Committee.
  • DR. JENNIFER LEE GEK CHOO, Independent Director and Chairman of the Nominating and Remuneration Committee
  • MS. CHEAH SUI LING, Independent Director and Chairman of the Audit and Risk Committee and Member of the Nominating and Remuneration Committee
  • MR. YONG YEAN CHAU, Chief Executive Officer and Executive Director
  • DR PREM KUMAR NAIR, Non-Executive Director and Member of Nominating and Remuneration Committee
  • DR. PETER CHOW, Non-Executive Director
  • DATO’ SRI MUTHANNA ABDULLAH, Non-Executive Director
  • MR. TOMO NAGAHIRO, Non-Executive Director

Experience and Expertise of the Board of Directors

MR. HO KIAN GUAN

MR. HO KIAN GUAN

Independent Director and Chairman of the Board of Directors and Member of the Audit and Risk Committee
Toggle Profile

WORK EXPERIENCE

Mr. Ho is the Executive Chairman of Keck Seng (Malaysia) Berhad since 1970 and also of Keck Seng Investments (Hong Kong) Limited since 1979. He was previously a Non-Executive Director of Shangri-la Asia Limited since 1993 and a member of its Audit Committee. He was previously the Director of Parkway Holdings Limited/Parkway Pantai Limited from 1985 to 2013 and was the Chairman of the Tender Committee.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

  • Business Administration and Commerce

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

  • Executive Chairman of Keck Seng Investments (Hong Kong) Limited
  • Executive Chairman of Keck Seng (Malaysia) Berhad

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

  • Non-Executive Director of Shangri-la Asia Limited
Dr. Jennifer Lee

DR. JENNIFER LEE GEK CHOO

Independent Director and Chairman of the Nominating and Remuneration Committee and Member of the Audit Committee
Toggle Profile

WORK EXPERIENCE

Dr. Lee serves on the boards of Parkway Trust Management Ltd and The Esplanade Company Ltd. Dr. Lee was the Chief Executive Officer (CEO) of KK Women’s and Children’s Hospital from 1991 to 2004. Before joining KK Hospital, she was the Chief Operating Officer of Singapore General Hospital from 1988 to 1991 during the period of its corporatisation, and prior to that served in the Ministry of Health in various portfolios. Her most recent work has been in development of the ageing sector, as Senior Consultant with the Ministry of Health’s Ageing Planning Office from 2007 to 2015 and Chairperson of the Agency for Integrated Care from 2009 to 2018.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

  • MBBS, National University of Singapore
  • MBA, National University of Singapore

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

  • Director of Parkway Trust Management Ltd
  • Director of Sheares Healthcare India Holdings Pte Ltd.

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

  • Director of The Esplanade Co Ltd
Ms. Cheah Sui Ling

MS. CHEAH SUI LING

Independent Director and Chairman of the Audit and Risk Committee and Member of the Nominating and Remuneration Committee
Toggle Profile

WORK EXPERIENCE

Ms. Cheah serves as Executive Board Chair of privately held ESG startup ecoSPIRITS and sits on the boards of several publicly-listed companies in Singapore. She is also Operating Partner at Wavemaker Partners, a tech-focused venture capital fund dual headquartered in Singapore and Los Angeles.

She previously spent more than 20 years in the investment banking industry. She started her career with Merrill Lynch New York, followed by stints in Singapore and London. Subsequently, she became Executive Director of Investment Banking at JP Morgan Singapore and later served as Co-head of Corporate Finance SEA at BNP Paribas.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

  • BA, Economics and French, Wellesley College, Massachusetts, USA

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

  • Executive Board Chair, ecoSPIRITS Pte Ltd
  • Independent Non-Executive Director of Pathology Asia Holdings Pte Ltd ( also Chairman of Audit Committee)
  • Independent Non-Executive Director of TeleChoice International Limited (also Member of Audit Committee)
  • Independent Non-Executive Director of M&C REIT Management Limited (also Member of Nominating and Remuneration Committee)
  • Independent Non-Executive Director of M&C Business Trust Management Limited
  • Venture Partner of Wavemaker Partners

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

  • Nil
MR. YONG YEAN CHAU

MR. YONG YEAN CHAU

Chief Executive Officer and Executive Director
Toggle Profile

WORK EXPERIENCE

Mr. Yong is the CEO and Executive Director of Parkway Trust Management Limited, the Manager of Parkway Life REIT.

Since its initial public offering in 2007, Mr Yong has led the REIT to more than double its asset portfolio value. Over the last 15 years, PLife REIT has also consistently delivered value to Unitholders, with Distributions Per Unit growing 127% since its IPO. The inclusion of PLife REIT in major indexes further affirmed the REIT’s strong position as one of the largest listed healthcare REITs in Asia. In 2022, PLife REIT was admitted into The Edge Singapore Billion Dollar Club and declared the winner of The Edge Singapore Billion Dollar Club 2022 — Highest Returns to Shareholders Over Three (3) Years. This award is testament of the Group’s overarching focus in driving continual growth and execution of sound core strategies in creating value to drive long-term sustainable returns for its Unitholders. At the same time, the award recognises excellence and places the Group amongst the best of companies in terms of corporate responsibility and sustainability listed on the Singapore Exchange (SGX), with at least SGD$1 billion in market capitalisation.

Mr. Yong’s deep expertise in finance and corporate strategy is attributed to his prior work experience as the CFO of the Singapore Tourism Board, overseeing its finance and corporate services functions. Prior to that, he was the CFO of Ascendas Pte Ltd (Ascendas). During his tenure with Ascendas, he was seconded to China-Singapore Suzhou Development Ltd and Singapore-Suzhou Township Development Pte Ltd as their CFO in Suzhou, China. Before joining Ascendas, Mr. Yong held other finance and audit positions at Beijing ISS International School, Housing and Development Board and Arthur Andersen.

ACADEMIC AND PROFESSIONAL QUALIFICATIONS

  • B.ACC (Hons), Fellow Chartered Accountant of Singapore
  • Advanced Management Programme with Harvard Business School

PRESENT DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS

  • Nil

PAST DIRECTORSHIPS OR CHAIRMANSHIP IN LISTED COMPANIES & MAJOR APPOINTMENTS HELD OVER THE PRECEDING 3 YEARS

  • Nil
DR PREM KUMAR NAIR

DR PREM KUMAR NAIR

Non-Executive Director and Member of Nominating and Remuneration Committee
Toggle Profile

WORK EXPERIENCE

Dr Prem Kumar Nair was appointed Group Chief Executive Officer of IHH Healthcare on 1 October 2023, where he leads a team of more than 65,000 employees to realise IHH’s vision to be the world’s most trusted healthcare services network.

Dr Nair sets the strategic direction for the sustainable growth of IHH’s global network which today comprises more than 80 hospitals in 10 countries. Guided by its Care. For Good. aspiration, Dr Nair continues to build on the IHH portfolio of strong and reputable brands including Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway - to touch lives and transform care globally.

Prior to his Group CEO appointment, he was CEO of IHH Singapore, where he oversaw the operations and management of IHH’s business units in the country and played an instrumental role in its strategic business growth and outreach efforts in overseas markets.

Dr Nair is a physician and healthcare executive with over three decades of experience in both public and private healthcare sectors. He was with Raffles Medical Group for 27 years, where he held concurrent roles as Chief Corporate Officer, and Managing Director for Singapore Healthcare. He is an Adjunct Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health.

An active community citizen, Dr Nair was a recipient of the Public Service Medal (Pingat Bakti Masyarakat) and the Public Service Star (Bintang Bakti Masyarakat) at the 2010 and 2022 National Day Awards respectively, for his contributions to the Singapore Prison Service. He is also a Justice of the Peace.

Dr Nair graduated from the National University of Singapore with a Bachelor of Medicine & Surgery, and a Master of Business Administration (Distinction) from Alliance Manchester Business School.

DR. PETER CHOW

DR. PETER CHOW

Non-Executive Director
Toggle Profile

WORK EXPERIENCE

As the Acting Chief Executive Officer of IHH Singapore from 1 October 2023, Dr Peter Chow oversees the operations and management of IHH’s business units in Singapore, which includes Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals, primary healthcare group Parkway Shenton, Parkway MediCentre, as well as ancillary and education entities such as Parkway Radiology, Parkway Rehab, Parkway Cancer Centre and Parkway College.

Dr Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020. Despite challenges from the Covid-19 pandemic, he led the hospital through a period of strategic development and growth, strengthening its position as a regional centre of clinical excellence. In 2022, he was awarded the Public Service Medal (Covid-19) for his healthcare leadership role during the pandemic and for supporting various national pandemic efforts in Singapore.

Dr Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. Trained as a dental surgeon with the National University of Singapore, he started his career as a dental officer. Subsequently he took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare.

Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics.

ACADEMIC/PROFESSIONAL QUALIFICATION(S)

  • Bachelor of Dental Surgery, National University of Singapore
  • Master of Health Science (Management), University of Sydney
  • Executive Program (Managing Health Care Delivery), Harvard Business School
DATO’ SRI MUTHANNA ABDULLAH

DATO’ SRI MUTHANNA ABDULLAH

Non-Executive Director
Toggle Profile

WORK EXPERIENCE

Dato’ Sri Muthanna Abdullah is a Barrister of Middle Temple and an Advocate and Solicitor of the High Court of Malaya. He read law at the University of Buckingham, England and was called to the Bar of England and Wales in 1982 and to the Malaysian Bar in 1983. He is a Consultant of Abdullah Chan & Co.

Dato’ Sri Muthanna was appointed as the Honorary Consul to Kuala Lumpur of the Republic of San Marino on 30 March 2017.

He is also a Director of IHH Healthcare Berhad, MSM Malaysia Holdings Berhad, MSIG Insurance Malaysia Berhad, Malaysian Life Reinsurance Group Berhad, Kuala Lumpur Business Club and a Trustee of The Habitat Foundation and Yayasan Siti Sapura.

MR. TOMO NAGAHIRO

MR. TOMO NAGAHIRO

Non-Executive Director
Toggle Profile

WORK EXPERIENCE

Mr. Tomo Nagahiro, aged about 47 years, was appointed to the Board of IHH in February 2023. Mr. Nagahiro was an alternate director on the Board of IHH from April 2019 to January 2023.

Mr. Nagahiro has been General Manager of Healthcare Services &Data Business Department in Wellness Business Unit of Mitsui & Co., Ltd (Mitsui), overseeing Mitsui's investment in IHH since April 2019.

He has over 20 years of working experience having served in multiple divisions in Mitsui, spanning from strategic planning, business development and operations management. Preceding his current appointment, he was seconded to MIMS Pte Ltd which is based in Singapore as the Chief Operating Officer from 2015 to 2018.

Prior to this, he was seconded to Parkway Pantai Limited, a wholly-owned subsidiary of IHH, as Assistant Vice President of Strategic Planning and Business Development where he led multiple business development projects from 2013 to 2015.

Mr. Tomo Nagahiro holds Bachelor of Arts in Law from University of Tokyo, Japan; Master of Business Administration from Kellogg School of Management, Northwestern University and is U.S. Certified Public Accountant.